Scientists Uncover Protein that Inhibits Coronaviruses
The research reveals that the LY6E protein impairs the coronavirus’ ability to initiate infection, which could lead to treatments for the illness.
ACE inhibitors and Angiotensin Receptor Blockers May Increase Mortality Rate In Elderly COVID-19 Patients
These highly prescribed medications change cell surface protein expression, which is particularly problematic in cells in the respiratory system—tissue that is vulnerable to targeting and attack by the COVID-19 virus.
20 Molecular Diagnostics Companies to Watch
Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
10 Liquid Biopsy Companies in the Money
10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.
10 Countries in 100K Genome Club
These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
8 Companion Diagnostic Developers Making a Mark
If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
Coronavirus Replication Stopped in 48 Hours in Lab-Grown Cells by Anti-Parasitic Drug
The studies showed that the drug, ivermectin, started to become effective against SARS-CoV-2 in lab-grown cells within just a day and “could essentially remove all viral RNA by 48 hours,” researchers said.
Italian Researchers Identify Common Susceptibility Genes in COVID-19 Patients
The researchers looked to identify genetic differences with clinical outcomes. Using that study form, for each patient, the team identified an average of three disease-causing mutations involved in COVID-19 susceptibility.
Abbott Launching ID NOW COVID-19 Tests, Offering Positive Results in Five Minutes
Company expects to deliver 50,000 tests per day of the rapid, instrument-based, isothermal system designed for qualitative detection of infectious diseases.
Four Promising Antiviral Drug Candidates Identified to Fight COVID-19
The researchers, based at University of South Florida Health and the University of Arizona College of Pharmacy, worked together to screen 55 possible antiviral compounds to assess their ability to treat SARS-CoV-2.
